AgomAb Therapeutics NV (AGMB)
NASDAQ: AGMB · Real-Time Price · USD
13.62
-0.59 (-4.15%)
At close: Mar 6, 2026, 4:00 PM EST
13.53
-0.09 (-0.66%)
After-hours: Mar 6, 2026, 4:02 PM EST
AgomAb Therapeutics NV Analyst Ratings
Total Analysts
3
Consensus Rating
Buy
Price Target
$32.00
Upside
+134.95%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Leerink Partners | Leerink Partners | Buy Initiates $36 | Buy | Initiates | $36 | +164.32% | Mar 3, 2026 |
| JP Morgan | JP Morgan | Buy Initiates $32 | Buy | Initiates | $32 | +134.95% | Mar 3, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $28 | Buy | Initiates | $28 | +105.58% | Mar 3, 2026 |